Paper21898545
CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
Bizet AA and 5 others. J Cell Biochem, 2012. Cited by 81 papers, by iCite.
Cite this record
ConductScience Library. CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function. Papers, record 21898545. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21898545
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, CD | Major topic |
| Neoplasm Proteins | Major topic |
| Protein Serine-Threonine Kinases | Major topic |
| Receptors, Transforming Growth Factor beta | Major topic |
| Smad7 Protein | Major topic |
| Transforming Growth Factor beta | Major topic |
| Ubiquitin-Protein Ligases | Major topic |
| Animals | |
| COS Cells | |
| Cell Line | |
| Chlorocebus aethiops | |
| GPI-Linked Proteins | |
| HEK293 Cells | |
| Humans | |
| Receptor, Transforming Growth Factor-beta Type I | |
| Receptor, Transforming Growth Factor-beta Type II | |
| Signal Transduction | |
| Ubiquitination |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| FRN13732 | Canadian Institutes of Health Research | Canada | PubMed |
Source PubMed
Cited by54
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42328435 | CD109 Drives Stemness and Chemoresistance in Colorectal Cancer via LRRC8A/AKAP12/PKCα-Mediated STAT3 Activation and WNT Signaling. | Int J Biol Sci | 2026 | https://conductscience.org/library/papers/42328435 | PubMed |
| 42064091 | The role of HECT-type E3 ubiquitin ligases in inflammation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42064091 | PubMed |
| 41898693 | CD109 Deletion Promotes Myofibroblast Differentiation and Smad-Dependent Matrix Accumulation in Skin Fibrosis. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/41898693 | PubMed |
| 41581882 | Antagonist nanobodies prevent protease inhibition by CD109. | J Biol Chem | 2026 | https://conductscience.org/library/papers/41581882 | PubMed |
| 40000880 | LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-β signalling. | Acta Pharmacol Sin | 2025 | https://conductscience.org/library/papers/40000880 | PubMed |
| 39990858 | CD109, a master regulator of inflammatory responses. | Front Immunol | 2024 | https://conductscience.org/library/papers/39990858 | PubMed |
| 39196190 | Cholesterol lowering depletes atherosclerotic lesions of smooth muscle cell-derived fibromyocytes and chondromyocytes. | Nat Cardiovasc Res | 2024 | https://conductscience.org/library/papers/39196190 | PubMed |
| 38161417 | FLOT2 promotes nasopharyngeal carcinoma progression through suppression of TGF-β pathway via facilitating CD109 expression. | iScience | 2024 | https://conductscience.org/library/papers/38161417 | PubMed |
| 38049323 | [Expression characteristics and clinical significance of CD109 in de novo acute myeloid leukemia]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | https://conductscience.org/library/papers/38049323 | PubMed |
| 36909248 | Smooth muscle αv integrins regulate vascular fibrosis via CD109 downregulation of TGF-β signalling. | Eur Heart J Open | 2023 | https://conductscience.org/library/papers/36909248 | PubMed |
| 36809715 | IL-4, IL-13 and IFN-γ -induced genes in highly purified human neutrophils. | Cytokine | 2023 | https://conductscience.org/library/papers/36809715 | PubMed |
| 36653343 | Genome-wide screen of otosclerosis in population biobanks: 27 loci and shared associations with skeletal structure. | Nat Commun | 2023 | https://conductscience.org/library/papers/36653343 | PubMed |
| 35954339 | CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35954339 | PubMed |
| 34504806 | Transforming Growth Factor-β1 Promotes M1 Alveolar Macrophage Polarization in Acute Lung Injury by Up-Regulating DNMT1 to Mediate the microRNA-124/PELI1/IRF5 Axis. | Front Cell Infect Microbiol | 2021 | https://conductscience.org/library/papers/34504806 | PubMed |
| 33797167 | TGF-β superfamily co-receptors in cancer. | Dev Dyn | 2022 | https://conductscience.org/library/papers/33797167 | PubMed |
| 32705187 | Activation of calcium‑sensing receptor‑mediated autophagy in high glucose‑induced cardiac fibrosis in vitro. | Mol Med Rep | 2020 | https://conductscience.org/library/papers/32705187 | PubMed |
| 32507856 | CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma. | Br J Cancer | 2020 | https://conductscience.org/library/papers/32507856 | PubMed |
| 32483604 | Network-based Transcriptome-wide Expression Study for Postmenopausal Osteoporosis. | J Clin Endocrinol Metab | 2020 | https://conductscience.org/library/papers/32483604 | PubMed |
| 32210029 | TGF-β Signaling. | Biomolecules | 2020 | https://conductscience.org/library/papers/32210029 | PubMed |
| 32133706 | Elevation of CD109 promotes metastasis and drug resistance in lung cancer via activation of EGFR-AKT-mTOR signaling. | Cancer Sci | 2020 | https://conductscience.org/library/papers/32133706 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD109 | 135228 | PubTator's text mining | https://conductscience.org/library/genes/135228 | NCBI Gene |
| SMAD7 | 4092 | PubTator's text mining | https://conductscience.org/library/genes/4092 | NCBI Gene |
| SMURF2 | 64750 | PubTator's text mining | https://conductscience.org/library/genes/64750 | NCBI Gene |
| TGFB1 | 7040 | PubTator's text mining | https://conductscience.org/library/genes/7040 | NCBI Gene |
| TGFBR1 | 7046 | PubTator's text mining | https://conductscience.org/library/genes/7046 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/21898545
GET https://conductscience.org/api/papers/v1/21898545/cited_by?page=2